1. Home
  2. OPBK vs KZIA Comparison

OPBK vs KZIA Comparison

Compare OPBK & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OP Bancorp

OPBK

OP Bancorp

N/A

Current Price

$15.21

Market Cap

230.9M

Sector

Finance

ML Signal

N/A

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

N/A

Current Price

$9.49

Market Cap

186.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPBK
KZIA
Founded
2005
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.9M
186.7M
IPO Year
2018
2002

Fundamental Metrics

Financial Performance
Metric
OPBK
KZIA
Price
$15.21
$9.49
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$17.75
★ $28.36
AVG Volume (30 Days)
33.7K
★ 297.9K
Earning Date
10-22-2026
11-06-2026
Dividend Yield
★ 3.73%
N/A
EPS Growth
★ 23.74
N/A
EPS
★ 1.02
N/A
Revenue
★ $3,204,000.00
N/A
Revenue This Year
$9.47
N/A
Revenue Next Year
$8.78
N/A
P/E Ratio
$14.80
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$12.41
$4.86
52 Week High
$16.83
$17.40

Technical Indicators

Market Signals
Indicator
OPBK
KZIA
Relative Strength Index (RSI) 42.04 35.96
Support Level $14.82 $9.01
Resistance Level $15.63 $14.85
Average True Range (ATR) 0.26 0.70
MACD -0.03 -0.05
Stochastic Oscillator 18.40 18.83

Price Performance

Historical Comparison
OPBK
KZIA

About OPBK OP Bancorp

OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: